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Abstract
Background—Conventional coronary artery disease risk factors might potentially explain at 
least 90% of the attributable risk of coronary artery disease. To better understand the association 
between the pre-industrial lifestyle and low prevalence of coronary artery disease risk factors, we 
examined the Tsimane, a Bolivian population living a subsistence lifestyle of hunting, gathering, 
fishing, and farming with few cardiovascular risk factors, but high infectious inflammatory burden.
Methods—We did a cross-sectional cohort study including all individuals who self-identified as 
Tsimane and who were aged 40 years or older. Coronary atherosclerosis was assessed by coronary 
artery calcium (CAC) scoring done with non-contrast CT in Tsimane adults. We assessed the 
difference between the Tsimane and 6814 participants from the Multi-Ethnic Study of 
Atherosclerosis (MESA). CAC scores higher than 100 were considered representative of 
significant atherosclerotic disease. Tsimane blood lipid and inflammatory biomarkers were 
obtained at the time of scanning, and in some patients, longitudinally.
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Findings—Between July 2, 2014, and Sept 10, 2015, 705 individuals, who had data available for 
analysis, were included in this study. 596 (85%) of 705 Tsimane had no CAC, 89 (13%) had CAC 
scores of 1–100, and 20 (3%) had CAC scores higher than 100. For individuals older than age 75 
years, 31 (65%) Tsimane presented with a CAC score of 0, and only four (8%) had CAC scores of 
100 or more, a five-fold lower prevalence than industrialised populations (p≤0-0001 for all age 
categories of MESA). Mean LDL and HDL cholesterol concentrations were 2.35 mmol/L (91 
mg/dL) and 1.0 mmol/L (39.5 mg/dL), respectively; obesity, hypertension, high blood sugar, and 
regular cigarette smoking were rare. High- sensitivity C-reactive protein was elevated beyond the 
clinical cutoff of 3.0 mg/dL in 360 (51%) Tsimane participants.
Interpretation—Despite a high infectious inflammatory burden, the Tsimane, a forager-
horticulturalist population of the Bolivian Amazon with few coronary artery disease risk factors, 
have the lowest reported levels of coronary artery disease of any population recorded to date. 
These findings suggest that coronary atherosclerosis can be avoided in most people by achieving a 
lifetime with very low LDL, low blood pressure, low glucose, normal body-mass index, no 
smoking, and plenty of physical activity. The relative contributions of each are still to be 
determined.
Funding—National Institute on Aging, National Institutes of Health; St Luke's Hospital of 
Kansas City; and Paleocardiology Foundation.
Introduction
Large-scale population studies have identified conventional coronary artery disease risk 
factors as important to the clinical manifestation of coronary artery disease events, and 
might explain more than 90% of the attributable risk of coronary artery disease.1 These data 
are supported by findings that nearly 50% of coronary artery disease risk can be reduced on 
adoption of a heart-healthy lifestyle, even in individuals with a higher genetic susceptibility 
to coronary artery disease.2 Additionally, multiple primary prevention studies have 
conclusively shown that the control of risk factors including cholesterol, smoking, 
hypertension, and diabetes lead to significant, consistent, and dose-related reduction in 
major adverse cardiac events.3-6 Populations with a lower prevalence of risk factors such as 
those that preceded modern lifestyles in industrialised settings should naturally show less 
prevalence of coronary disease.
Previous research by the HORUS Study Team on atherosclerosis in a pre-modern era has 
focused on mummies, observing peripheral atherosclerosis to be common in multiple 
ancient populations.7,8 Atherosclerosis was confirmed by demonstration of calcific deposits 
in arterial beds. High inflammatory exposure from infection and presumptive abundance of 
risk factors was hypothesised to play a part in the pathogenesis of coronary artery disease in 
these populations.9 Conversely, contemporary pre-industrial populations have shown either 
lower prevalence of peripheral atherosclerosis,10,11 or coronary risk factors.12,13 On the 
basis of carotid and femoral ultrasound studies (Heart Attack Prevention Programme for 
You, HAPPY), atherosclerosis in a physically active, strictly vegetarian, non-smoking, and 
regularly meditating suburban population in India was encountered a decade and a half later 
than the comparable population in Texas, USA.10,11 Similarly, the Tsimane Health and Life 
History Project team (THLHP) has been working with the indigenous Tsimane of Bolivia, a 
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population of 16 000 individuals that live a pre-industrial lifestyle of hunting, gathering, 
fishing, and farming along the Maniqui River, an Amazon River tributary. The indirect 
measures of vascular ageing indicate that the Tsimane have low rates of hypertension and 
arterial stiffness.12,13 Although the Tsimane have a low prevalence of coronary risk factors, 
they are similar to ancestral subsistence populations in their high infectious burden 
associated with high levels of biomarkers of inflammation.
To better understand the association between the preindustrial lifestyle and low prevalence 
of coronary artery disease risk factors, the HORUS Study Team and THLHP joined to 
collaboratively examine the hypothesis that an active subsistence lifestyle, resembling an era 
before sedentary urbanisation and large-scale economic specialisation, would be associated 
with low levels of manifest coronary artery disease, despite high inflammation from 
parasites and pathogens. To do so, we used direct coronary artery visualisation by CT for 
quantification of extent, severity, and location of coronary artery calcium (CAC) in 705 
Tsimane adults. CAC scoring is a safe, non-invasive test commonly done by CT that enables 
quantification of CAC extent, severity and location; CAC scoring can now be accomplished 
with minimal radiation burden.14 An array of population-based and observational cohort 
registries have proved the prognostic usefulness of CAC scores beyond traditional coronary 
artery disease risk factors and non-coronary measures of peripheral atherosclerosis.15
Methods
Study design and participants
The THLHP has been working with the Tsimane population since 2002, and in 2011, 
expanded its coverage to 85 Tsimane villages, sampling individuals aged 40 years or older in 
a cohort-based panel design. This cross-sectional sample includes all individuals who met 
the inclusion criteria of self-identifying as Tsimane and who were aged 40 years or older 
(see appendix for age estimation methods). The THLHP makes regularly scheduled visits to 
Tsimane villages every 18 months, during which clinical examinations are performed and 
blood samples collected to examine within and cross population variations of the ageing 
process.12,13,16,17
Individuals ranged between 40 years and 94 years of age. We focused our efforts on 
individuals older than 60 years. Due to the pyramidal population structure, we used a 
random number generator to select communities in which to sample individuals aged 40–59 
years. We elected to randomly sample at the community level rather than the individual level 
for reasons of cultural appropriateness, so specific individuals would not feel targeted or left 
out.
This study was approved by the University of New Mexico and University of California, 
Santa Barbara Human Subjects Review Committees. Written informed consent was obtained 
from participants, after having had the procedure and risks explained to them in their native 
language, from each village, and the Tsimane Government (Gran Consejo). The radiation 
dose was relatively low, and all the participants were mature adults older than 40 years.
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Procedures
Individuals underwent CAC scanning by electrocardiogram (ECG)-gated CT imaging using 
a 16-detector row scanner (GE Brightspeed, Milwaukee, WI, USA) between July, 2014, and 
September, 2015. A licensed radiological technician acquired a single, ECG-gated scan 
(appendix). Scans were supervised and reviewed by at least one of the team cardiologists. A 
central core laboratory, whose members were masked to participant data, performed calcium 
scoring of the coronaries using semi-automatic software (GE SmartScore 4.0, Milwaukee, 
WI, USA) according to the method of Agatston and colleagues.18
Tsimane CAC scores were compared with published scores of population-based studies in 
high-income countries, including the US Multiethnic Study of Atherosclerosis (MESA),15 
the German Heinz-Nixdorf Recall (HNR) study,19 and eleven other CT studies20-25 
(appendix). Because of the variable reporting of age categories across published studies, we 
could not directly compare studies in Tsimane with other studies at the individual level, and 
instead assessed differences in CAC by age across broader age categories. Most of these 
studies excluded adults with coronary artery disease or symptoms at baseline, therefore 
providing lower-bound population estimates of CAC. Tsimane CAC protocols were similar 
to these studies.24 As published reports8,21-23 typically stratify CAC scores as 0 (almost no 
risk), 1–99 (low risk), 100–399 (moderate risk), and 400 or greater (high risk), we compared 
our findings with those published results. We used the same categories as those previously 
published, except that we combined the two highest categories since there was only one 
Tsimane individual with a CAC score of 400 or above.
Following fasting morning blood draws, blood testing included lipids, oxidised LDL 
cholesterol, apolipoprotein A and B, glucose, high sensitivity C-reactive protein (hs- CRP), 
erythrocyte sedimentation rate, five-part differential of white blood cells, and nine cytokines 
(appendix).
Statistical analysis
To assess the association between coronary artery disease risk factors and Tsimane CAC 
scores, we did a multivariate zero-inflated negative binomial regression;26 this approach is 
specifically designed for distributions with a large fraction of “zero” CAC scores and 
overdispersion, as are the Tsimane CT data. The model simultaneously performs a logistic 
regression to test for factors that inflate CAC absence, and a negative binomial regression to 
examine factors associated with CAC scores (including zeros and positive scores), while 
controlling for age and sex. Standard linear models perform poorly with such distributions, 
although a comparison using the standard approach shows that the zero-inflated negative 
binomial model explains more of the variance and fits the data better (appendix). Hs-CRP 
was log transformed for normality, and all statistics were run in Stata, version 14.2. All risk 
factors were tested for interaction with sex, and none of those interactions were significant. 
The model presented in this study is a post- hoc subset of variables that significantly predict 
attributable CAC risk; Akaike’s Information Criteria were used for model selection.
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Role of the funding source
The funders of the study had no role in the study design, data collection, or data analysis, 
data interpretation, or writing of the report. HK, RCT, BCT, CEF, MG, and GST had full 
access to all the data in the study and had final responsibility for the decision to submit for 
publication.
Results
Between July 2, 2014, and Sept 10, 2015, 705 individuals were included in this study. 
Individuals older than 60 years who were not sampled had either recently migrated between 
communities after major flooding (n=49), did not wish to participate because they were 
hunting, working in their fields, or engaged in childcare (n=15), or refused to participate 
(n=2). Only one individual refused to participate because of poor health or inability to travel 
(recovering from a hernia surgery; figure 1). To address potential sources of bias, analyses 
comparing individuals who had a CT versus those who did not have a CT showed no 
significant differences in sex (p=0.634), systolic (p=0.301) or diastolic (p=0.301) blood 
pressure, or body fat (p=0.942); our sample is therefore representative of all individuals over 
the age of 40 years.
There were several reasons for the extremely high participation rate. First, the long-term 
presence of the THLHP, combined with medical assistance, created an atmosphere of trust 
and collaboration. Second, individuals who had travelled to the city of Trinidad for CT 
scanning were given free access to medical specialists and treatment for any ailments they 
presented with. Third, all food, travel, and lodging were provided free of cost and 
administered by the THLHP team. Finally, we provided compensation for participants’ time, 
including subsistence tools, needles, and yarn. CT scanning showed incidental findings 
(appendix) in 72 people who were referred to specialists (92% to pulmonologists for 
Mycobacterium tuberculosis).
Baseline characteristics for the study population are listed in table 1. The mean age of the 
study population was 57.6 years (95% CI 41–92); 356 (50%) of 705 participants were 
women (table 1). Younger individuals had a higher weight, height, and body-mass index 
(BMI). Older individuals had higher systolic and diastolic blood pressures and higher heart 
rates.
Prevalence of coronary artery disease risk factors, including blood pressure, and cholesterol 
and glucose concentrations, were low in all age groups (table 1). Prevalence of smoking was 
also low. Although 201 (28%) adults reported occasional smoking, the mean number of 
cigarettes smoked was roughly ten per month in those who smoked (ie, 0.5 pack years over a 
lifetime). No differences were observed across age groups for hypertension, 
hypercholesterolaemia, obesity, or diabetes. Hs-CRP concentrations of higher than 3.0 mg/L 
were deemed clinically elevated,27 and were reported in 360 (51%) of Tsimane participants; 
mean CRP was 3.7 mg/L (table 1). No differences were observed across age groups for the 
extent of inflammation as determined by erythrocyte sedimentation rate or hs- CRP.
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We observed a very low prevalence of coronary atherosclerosis in Tsimane as measured by 
CAC scoring. 596 (85%) of 705 participants had no CAC, 89 (13%) participants had CAC 
scores lower than 100, and only 20 (3%) had CAC scores of 100 or higher (figures 2–4, 
appendix). Figure 2 compares the age-specific prevalence of Tsimane and the US MESA 
sample with either no CAC or CAC scores of more than 100. Compared with MESA, a 24-
year lag is observed before Tsimane reach a CAC score of more than 0, and a 28-year lag 
before Tsimane reach a CAC score of 100 or higher. Figure 3 shows that the rate of 
progression of atherosclerosis to coronary artery disease is much slower among the Tsimane 
than in the MESA cohort, and even Tsimane men show a much flatter progression with age 
than MESA women (of note, the scale for MESA men [0-4800] is three times the scale for 
MESA women and for Tsimane men and women [0-1600]). These findings extended to later 
life where, after age 75 years, 31 (65%) Tsimane were free from CAC and only four (8%) 
had moderately increased CAC scores. These findings of apparent athero-protection 
experienced by the Tsimane extended to both sexes. CAC scores are normally two to four 
times higher in men than in women.15,20-23 Although Tsimane men had higher CAC scores 
than Tsimane women, a finding more prominent in the older population, Tsimane men had 
lower CAC scores than Japanese women, a population previously regarded as having the 
lowest CAC scores reported for any ethnicity (figure 4).
Significant predictors of a CAC score greater than 0 were age, body-fat percentage, hs-CRP, 
and erythrocyte sedimentation rate. Other inflammatory markers, including neutrophil and 
monocyte count, and interleukin 10 and interleukin 5, were increased for individuals with 
CAC scores higher than 0. Table 2 shows the results of the best-fit model of predictors of 
CAC, derived from the zero- inflated negative binomial regression model and delineating 
significant predictors of both CAC absence (lower portion) and CAC score (upper portion). 
The coefficients report the attributable risk in terms of incidence rate ratios for unit changes 
in the independent variable. The lower portion shows that younger age, female sex, and 
lower triglycerides are associated with greater likelihood of CAC absence. The upper portion 
of the table shows that age, and to a lesser extent body fat and hs-CRP, are positively 
associated with CAC scores. Monocyte counts, however, are negatively associated with CAC 
scores. With the very low prevalence and level of CAC within the Tsimane population, the 
model explains only 19% of the attributable risk, with age and sex accounting for 14% of the 
attributable risk, and all other risk factors accounting for the remaining 5%. Risk factors 
from table 1 across categories of CAC score risk group and a comparison of this model to a 
more standard log linear model in which log (CAC+1) is regressed on risk factors are shown 
in the appendix.
Discussion
In this population-based study of the indigenous Tsimane population of Bolivia, we 
observed a very low prevalence of coronary atherosclerosis, as measured by CAC scoring. 
The low prevalence of atherosclerosis extends to the older ages wherein up to 31 (65%) 
Tsimane octogenarians were free from atherosclerosis; only four (8%) of octogenarians 
showed moderately elevated CAC scores. This makes the Tsimane the population with the 
least reported coronary atherosclerosis. This contrasts starkly with the US MESA population 
in which only 14% of the MESA population had no CAC, and more than 50% exhibited 
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CAC scores of at least 100 Agatston units. These findings translate to a 24-year lag before 
Tsimane reach a CAC score of above 0 and a 28-year lag before they reach a CAC score of 
at least 100 compared with an unselected US population (figures 2–4). By these findings, an 
80-year old Tsimane possesses the “vascular age” of an American individual in their mid 
fifties. These findings of apparent protection from coronary atherosclerosis in the Tsimane 
extend to old age.
The pathophysiological mechanisms by which the Tsimane seem to be protected against 
CAC development are unknown. Numerous potential explanations exist, and might relate to 
coronary artery disease risk factors, subsistence lifestyle, genetics, and inflammation or 
immune regulation. Tsimane have low total and LDL cholesterol. From 2004 to 2011, the 
mean LDL cholesterol was 1.84 mmol/L (SD 0.57; appendix).13 Since 2011, average LDL 
cholesterol has increased by 0.16 mmol/L per year and now averages 2.35 mmol/L. This 
change is coincident with the availability of small gasoline motors that preclude the need for 
manual canoeing or rafting for river travel to the market town, San Borja, where 
nonsubsistence food can be obtained. Whether the increasing LDL-cholesterol 
concentrations coincide with increasing CAC will require assessment in future studies. This 
low prevalence and extent of CAC exists in the presence of low HDL, a known coronary 
artery disease risk factor. In the Tsimane, the average HDL was 1.0 mmol/L. This finding 
might highlight a differential weight to LDL versus HDL cholesterol for CAC formation or, 
alternatively, might be explained by ratios of total cholesterol or LDL cholesterol to HDL 
cholesterol that place Tsimane individuals in a low-risk category when using US-based 
classifications. Lower HDL cholesterol might also contribute to a higher likelihood of 
infections and inflammation.29
The potentially atheroprotective effect of low LDL or LDL-to-HDL ratio might be partly 
augmented by the Tsimane lifestyle. The Tsimane live a traditional forager- horticultural 
lifestyle, in huts of thatched roofs, typically in villages of roughly 60-200 people (figure 5). 
An estimated 14% of their average caloric diet is protein, 14% is fat, and 72% is 
carbohydrate.30 Meat protein and fat are acquired by hunting with guns and bow and arrow, 
or fresh water fishing with arrows, hook and line, or nets. Non-processed carbohydrates are 
grown in the form of rice, plantain, manioc, and corn via slash-and-burn horticulture, and the 
Tsimane also gather wild nuts and fruits. Importantly, carbohydrates are high in fibre and 
very low in saturated fat and simple sugars, which might further explain our study findings. 
The Tsimane diet lacks trans fats, and is a low fat diet, with an average estimated daily 
consumption of 38 g fat, with 11 g saturated fat, 14 g monounsaturated fat, and 8 g 
polyunsaturated fat.30 Most of a typical Tsimane day involves the physical activity of 
farming, hunting, food preparation, household chores, and parenting. The average hunt lasts 
more than 8 h and covers nearly 18 km, while horticultural labour includes using metal axes 
to chop large areas of primary forest. Men and women spend a mean of 6–7 h and 4–6 h per 
day engaging in physical activity, respectively.16 Less than 10% of Tsimane daylight hours 
are spent engaged in sedentary activity, while more than 54% of waking hours are sedentary 
in industrial populations.16,31 The Tsimane lack access to clean water, sewerage, or 
electricity; over two- thirds of adults suffer from intestinal helminths at any given time.32 
The low prevalence of coronary artery disease in the Tsimane extends indirect evidence 
found in other populations33,34 that an active subsistence lifestyle is atheroprotective.
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This present study findings are in agreement with, and extend the findings of, a MESA 
substudy regarding western heart-healthy behaviours and arterial ageing, which assessed 
later life adults exhibiting CAC scores of 0 at baseline by serial CT at 5 years after index CT.
35 Importantly, this study noted that absence of traditional coronary artery disease risk 
factors in aggregate were associated with slower progression of CAC, but that the absence of 
the risk factors individually might not be associated with slower CAC progression. Recently, 
a heart-healthy western lifestyle was associated with a 46% decrease in coronary artery 
disease events.2 This lifestyle was defined as meeting three of four healthy lifestyle factors 
from the American Heart Association goals, including no smoking, a BMI of less than 30, 
physical activity of moderate intensity at least once a week, and a healthy diet pattern.2 
These findings are directly applicable to the Tsimane, almost all of whom meet and exceed 
the American Heart Association goals.
Although genetics plays a minor part in causation of coronary artery disease,1 individuals 
with loss of function mutation of PCSK9 have been described with very low levels of LDL 
cholesterol and substantial freedom from major adverse coronary events.36,37 Because of the 
gradually increasing cholesterol levels in Tsimane over time with marker integration, they do 
not seem to be genetically protected. Presumptively, if the genetic makeup of the South 
American Tsimane is similar to North Americans, the Tsimane diet and exercise lifestyle 
might offer evidence to advocate for targets for effective primary prevention of 
atherosclerosis. However, the subsistence lifestyle in which each individual hunts, grows or 
gathers his own food, and exercises half the day, is impractical in an industrialised society. 
Furthermore, whether there is a threshold effect for diet and exercise above which no gain is 
achieved for slowing progression of CAC is unknown. Future studies addressing this issue 
might have strong implications on defining healthy behaviours for heart disease prevention.
Previous clinical trials and observational studies have supported the hypothesis of 
atherosclerosis as an inflammatory disease.9 However, whether inflammation is associative 
or causal in the coronary artery disease pathway remains unknown. Previous studies in 
industrialised civilisations have observed a dose-response association between inflammatory 
markers such as hs- CRP and future adverse coronary artery disease events.9 In this study, a 
high inflammatory burden was observed in the Tsimane with a low prevalence of CAC for 
all inflammatory markers (table 1). The current study used single measures of hs-CRP and 
other inflammatory biomarkers, previous work by the THLHP showed strong consistency in 
immune activation across multiple time points, suggesting much of the increased 
inflammation among Tsimane is chronic.30 Hs-CRP was marginally associated with CAC 
presence, but other inflammatory markers such as erythrocyte sedimentation rate, neutrophil 
count, interleukin 5, and interleukin 10 were noted to be inversely proportional to CAC. 
These findings run counter to previous industrialised population studies, for which the 
opposite has been found.9 Inflammation in the presence of low LDL concentrations might 
not potentiate the atherosclerotic process, although this might depend on the type and 
severity of infection.
Our study is not without limitations. We employed CAC scoring as a direct measure of 
coronary atherosclerosis, but its non-contrast nature precludes assessment of non- calcified 
plaque constituents. Although other methods of coronary assessment using contrast-
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enhanced coronary CT angiography or intravascular imaging might have afforded more 
information gain, we elected not to do so for reasons of safety. Yet, to date, CAC has 
emerged as a robust indicator of future coronary artery disease risk in population-based and 
observational cohort studies in industrialised environments.
While the prognostic implications of CAC in the Tsimane were beyond the scope of this 
study, increasing CAC extent and severity has been associated with higher rates of death and 
adverse coronary artery disease outcomes in previous investigations. Tsimane adults die at a 
modal age of 70 years (the most common age at the time of death), with cause-specific death 
ascertained by verbal autopsies using the WHO instrument. In a sample of 50 adult deaths 
occurring over the past 5 years, we identified only one potential case of death due to 
myocardial infarction (appendix).
Although we aimed to study all Tsimane individuals aged at least 40 years, this was not 
achievable because some individuals were not available for consenting and a few others 
refused consent. Yet, in this asymptomatic population of individuals, those who did versus 
those did not consent to study participation did not differ for coronary artery disease risk 
factors. We further compared CAC findings of the Tsimane to that of the population- based 
MESA study, which possessed a different make-up and frequency of sex and ethnicity to the 
current study. We considered a matched population of Tsimane to a US population, but 
elected to maximise the number of participants who could be effectively compared by 
including all individuals undergoing CAC scanning. With a low prevalence of coronary 
artery disease risk factors, heart-healthy lifestyle, high infectious inflammation, and low 
CAC, the Tsimane, a forager-horticulturalist population of the Bolivian Amazon, have the 
lowest reported levels of coronary artery disease of any population ever recorded to date. 
These findings suggest that coronary atherosclerosis can be avoided in most people by 
achieving a lifetime with very low LDL, low blood pressure, low glucose, normal BMI, no 
smoking, and plenty of physical activity. The relative contributions of each are still to be 
determined.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Research in context
Evidence before this study
We searched both PubMed and Google Scholar for articles with terms “coronary 
calcium” and “CAC” (coronary calcium scoring) published after 1990 with no language 
restrictions. We searched for all population-based studies of coronary artery disease using 
CAC to determine whether data have been published on prevalence and severity of 
disease in small-scale subsistence populations and to integrate all available data. We 
included studies that were either population-representative or of very large sample size 
with explicit sampling methodologies described.
Added value of this study
The findings of the present study show that, in comparison to existing evidence, Tsimane 
indigenous South Americans have the lowest prevalence of coronary atherosclerosis of 
any population yet studied. This was achieved despite a high infectious inflammatory 
burden.
Implications of all the available evidence
The available evidence suggests that a lifetime with very low LDL cholesterol, a 
subsistence diet of wild game, fish, and high-fibre carbohydrates that are very low in 
saturated fat, combined with physical activity throughout much of the day sets a new 
target in the prevention of coronary atherosclerosis. Although consuming a subsistence 
diet is generally not feasible in urban industrialised populations, adoption of certain 
aspects of subsistence lifestyles could benefit individuals in sedentary industrialised 
populations. Urbanisation and the elimination of a subsistence diet and lifestyle might 
represent a novel risk factor for coronary artery disease. The general lack of prediction of 
CAC by inflammatory biomarkers in this study suggests the potential of a threshold effect 
for either degree of coronary atherosclerosis or LDL cholesterol level required for 
inflammation to either cause or predict coronary artery disease. Alternatively, 
inflammation secondary to infection might not be causal.
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Figure 1. 
Study profile
*Data were missing mainly because of broken laboratory equipment, electricity issues, 
missing supplies, or absent or sick laboratory personnel; data were missing for blood 
biomarkers, cholesterol, body fat, and confidence in the validity of the age estimate.
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Figure 2. 
CAC scores by age for US MESA, and Tsimane samples
Tsimane have significantly lower CAC for each age category (all p ≤0.0001). Raw data and t 
tests for differences between Tsimane and MESA23 are given in the appendix. Error bars 
show 95% CI. CAC=coronary artery calcium.
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Figure 3. 
CAC score by age and CAC percentile in MESA white men (A) and Tsimane men (scaled to 
MESA men at 0-4800; B) and in MESA white women (C) and Tsimane women (D) and 
Tsimane men (scaled to MESA women at 0-1600; E)
Raw Tsimane data in five percentile groups for each age group15 are in the appendix. 
MESA=Multi-Ethnic Study of Atherosclerosis. CAC=coronary artery calcium.
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Figure 4. 
75th percentile of CAC score in women (A) and men (B) across populations
Data sources are in the appendix. Data were used from the Heinz Nixdorf RECALL Study 
(HNR),19 the Multi-Ethnic Study of Atherosclerosis (MESA),20-21,23 Japan,22 the Mid 
America Heart Institute (MAHI),24 the University of Illinois at Chicago,25 and Korea.28 A 
bootstrapped 95% CI is displayed for the Tsimane data. CAC=coronary artery calcium.
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Figure 5. 
An extended Tsimane family at the entrance to their home (A), two sisters and their children 
harvesting manioc root (B), a man and his son fishing with bow and arrow (C), and two men 
butchering a deer after hunting in the forest (D)
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Table 2
Zero-inflated negative binomial model predicting Tsimane CAC scores
IRR 95% CI p value
Predictor of CAC score
Age (years)   1 07   1 04 to 1.11 <0.0001
Male sex   2 86   1 10.to 745   0 0311
Body fat (%)   1 11   1 06 to 1.18   0 0001
Interleukin-10 (pg/mL)   0 85 075 to 0.96   0 0106
Interleukin-5 (pg/mL)   0 77   0 62 to 0.95   0 0145
Log hs-CRP (mg/L)   1 71   1 16 to 2.51   0 0070
Monocyte count (per 1000)   0 005   0 00 to 0.23   0 0070
Neutrophil count (per 1000)   0 83   0 70 to 0.98   0 0282
ESR (mm/h)   0 97   0 95 to 1.00   0 0377
Intercept   0 32   0 03 to 398   0 3765
Predictor of CAC absence
Age –0.07 –0.10 to –0.04 <0.0001
Male sex –1.23 –1.84 to –0.63   0 0001
HDL –0.04 –0.07 to 0.00   0 0474
Triglycerides –0.01 –0.02 to 0.00   0 0125
Intercept   8 63   6 14 to 11.13   0 0006
IRRs indicate the proportional change in risk for each dependent variable. IRRs greater than 1 indicate increased risk, and less than 1 increase 
reduced risk. The upper section displays significant predictors of non-zero scores, while the lower section displays the significant predictors of 
“inflated” scores of zero. Overall, the model accounts for 19% of the variance in CAC. IRR=incident rate ratio. CAC=coronary artery calcium. hs-
CRP=high sensitivity C-reactive protein. ESR=erythrocyte sedimentation rate.
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